5-HTTLPR and BDNF Val66Met polymorphisms and response to rTMS treatment in drug resistant depression
Authors:
- Luisella Bocchio-ChiavettoLuisella Bocchio-Chiavetto
- Carlo MiniussiCarlo Miniussi
- Roberta ZanardiniRoberta Zanardini
- Anna GazzoliAGAnna Gazzoli
- Stefano BignottiSBStefano Bignotti
- Claudia SpecchiaCSClaudia Specchia
- Massimo GennarelliMassimo Gennarelli
- 1 May 2008
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 437 (2) , 130-134
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Transcranial Magnetic Stimulation: Potential New Treatment for Resistant DepressionThe Journal of Clinical Psychiatry, 2007
- Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patientsMolecular Psychiatry, 2006
- Genetic Variant BDNF (Val66Met) Polymorphism Alters Anxiety-Related BehaviorScience, 2006
- The 196G/A (val66met) polymorphism of the BDNF gene is significantly associated with binge eating behavior in women with bulimia nervosa or binge eating disorderNeuroscience Letters, 2006
- Neurostimulation in resistant depressionJournal of Psychopharmacology, 2006
- Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patientsJournal of Affective Disorders, 2006
- Modulation of monoamine transporter expression and function by repetitive transcranial magnetic stimulationBiochemical and Biophysical Research Communications, 2005
- Transcranial Magnetic Stimulation in the Treatment of DepressionAmerican Journal of Psychiatry, 2003
- The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal FunctionCell, 2003
- Allelic Variation of Human Serotonin Transporter Gene ExpressionJournal of Neurochemistry, 1996